TABLE 2.
Metrics on COVID‐19, GDP, and Research funding within countries sampled as of the time of the interviews
| Country | COVID cases as of June 15, 2020 | Population | Infection rate per 100K | GDP (2019) (billions) (USD) | Per‐capita GDP (2019) (USD) | R&D as percent of GDP (2018 figures) |
|---|---|---|---|---|---|---|
| Canada | 100 763 | 37 742 154 | 267.0 | $1740 | $46 195 | 1.57% |
| China | 84 378 | 1 439 323 776 | 58.6 | $14 340 | $10 262 | 2.19% |
| Egypt | 46 289 | 102 334 404 | 45.2 | $303.1 | $3019 | 0.72% |
| Finland | 7108 | 5 540 720 | 128.3 | $269.3 | $48 783 | 2.77% |
| France | 197 004 | 65 273 511 | 301.8 | $2720 | $40 494 | 2.20%. In 2020, public research funding was 16 billion Euro; expected to increase to 21 billion Euro in 2021 https://www.nature.com/articles/d41586‐020‐02217‐4 |
| Germany | 187 682 | 83 783 942 | 224.0 | $3860 | $46 445 | 3.09% |
| Iran | 189 876 | 83 992 949 | 226.1 | $454 | $5550 | 0.83% |
| Italy | 237 290 | 60 461 826 | 392.5 | $2000 | $33 228 | 1.40% |
| Tunisia | 1110 | 11 818 619 | 9.4 | $38.8 | $3318 | 0.60% |
| United Kingdom | 273 888 | 67 886 011 | 403.5 | $2830 | $42 330 | 1.72% |
| United States | 2 110 000 | 331 002 651 | 637.5 | $21 430 | $65 298 | 2.84% |
Source for infection rates as of June 15, 2020: https://ourworldindata.org/coronavirus/country/finland?country=~FIN–cumulativecasestable
Population estimates: https://www.worldometers.info/world‐population/population‐by‐country/
Per‐capita GDP: https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=EG
Research funding as percent of GDP source: https://data.worldbank.org/indicator/GB.XPD.RSDV.GD.ZS